We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
32.00 | 1.91% | 1,705.00 | 1,701.00 | 1,701.50 | 1,718.50 | 1,673.00 | 1,685.50 | 5,853,296 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.21 | 70.03B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2020 11:47 | Yes A J Bell are very good when it comes to quick access to your dividends. Halifax Share Dealing are the opposite! | aimtoretire | |
09/4/2020 10:46 | My dividends from AJ Bell were in my accounts before opening. Looking to recycle into GSK now …… ;0) | tradermichael | |
09/4/2020 10:39 | Divi credited @ between 12-1pm | abdullla | |
09/4/2020 08:26 | Thanks Michael - that's fantastic. I thought I had read you had been doing this with your stocks ISA - really appreciate you getting back to me | bilster1 | |
09/4/2020 08:12 | Bilster - yes, a Stocks and Shares ISA account can be used to buy and sell GSK etc. like a normal dealing account. I trade all the time like this (repeatedly), with cash accumulated from the annual allowance (I put in £20K per year), profits from disposals and from the dividends that have accumulated in the account. You are not required to declare any of the gains (capital gains and dividends) because this type of account is tax exempt. | tradermichael | |
08/4/2020 20:06 | Thanks Gateside - really appreciate the heads up ? #staysafe and good luck with the markets - Bw Bilster | bilster1 | |
08/4/2020 19:16 | Blister... Once you have put your 20k or less, in your ISA you can trade it as often as you like. | gateside | |
08/4/2020 18:56 | Hi Michael - hope you don't mind me asking but can you trade shares within your ISA shares account, say weekly looking for the pull backs - ie as the stocks are so volatile at the moment - trading with the 20k I know it's not the norm but wasn't sure if you did it? Would really appreciate your advice? | bilster1 | |
08/4/2020 14:28 | GSK should buy Ncyt,mcap is peanuts,but is becoming a world leader in testing! | costax1654x | |
08/4/2020 14:27 | GSK covered by Tempus today, although unfortunately it's behind a paywall: | zho | |
08/4/2020 10:21 | I'll be reinvesting mine back in GSK | gateside | |
08/4/2020 10:19 | Div 23p/share paid tomorrow. Whack it all onto GSK …… ;o) | tradermichael | |
08/4/2020 08:39 | AV. caved. | eeza | |
08/4/2020 07:58 | Ncyt mcap is below 200 mil | costax1654x | |
08/4/2020 07:47 | Pascal Soriot interviewed on Radio 4 from 7.32 | zho | |
08/4/2020 07:43 | NCYT- the virus testing company- has published an RNS this morning declaring that NCYT, GSK and AZN will be collaborating with the University of Cambridge in further development of Covid-19 tests. | enteleon | |
07/4/2020 18:01 | AV up after L&G basically refused to shelve their dividend payout. LGEN too of course... | edmundshaw | |
07/4/2020 14:38 | Many of those up have been seriously hammered some more than 50% relatively GSK has not fallen that much. | tim 3 | |
07/4/2020 12:50 | AZN only down today sud. Overall AZN has easily outperformed GSK. | igoe104 | |
07/4/2020 12:43 | It's a risk on day, cyclicals and financials should outperform, in general terms. | essentialinvestor | |
07/4/2020 12:35 | AZN down 2% igoe!spud | spud | |
07/4/2020 12:10 | Christh, most stocks are up at least 5%. these are doing nothing, AV up 13.8% at the moment. | igoe104 | |
07/4/2020 12:06 | montyhedge7 Apr '20 - 10:19 - 21079 of 21084 Shareprice going nowhere. its up you idiot | christh | |
07/4/2020 11:09 | Thursday I think you'll find igoe. spud | spud | |
07/4/2020 11:09 | I don't know how many posters follow the presentation and disclosure of R&D costs here. Ex 1 - costs of R&D in their own labs. Ex 2a - buy in of a third party's R&D from a listed company. Ex 2b - buy in of a third party's R&D from a non listed company. Huge numbers. | alphorn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions